The APPROACH trial: volanesorsen lowers triglyceride levels in patients with familial chylomicronemia
1. Triglyceride levels in familial chylomicronemia patients were notably reduced when treated with the apolipoprotein C-III antisense mediated inhibitor volanesorsen...